Breckenridge Pharm Company Profile
✉ Email this page to a colleague
What is the competitive landscape for BRECKENRIDGE PHARM
BRECKENRIDGE PHARM has five approved drugs.
There is one tentative approval on BRECKENRIDGE PHARM drugs.
Summary for Breckenridge Pharm
| US Patents: | 0 |
| Tradenames: | 5 |
| Ingredients: | 5 |
| NDAs: | 5 |
| Patent Litigation for Breckenridge Pharm: | See patent lawsuits for Breckenridge Pharm |
| PTAB Cases with Breckenridge Pharm as petitioner: | See PTAB cases with Breckenridge Pharm as petitioner |
Drugs and US Patents for Breckenridge Pharm
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Breckenridge Pharm | ESTRADIOL AND NORETHINDRONE ACETATE | estradiol; norethindrone acetate | TABLET;ORAL | 078324-002 | Jun 9, 2011 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Breckenridge Pharm | METHSCOPOLAMINE BROMIDE | methscopolamine bromide | TABLET;ORAL | 040642-002 | Dec 6, 2011 | AA | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Breckenridge Pharm | OXCARBAZEPINE | oxcarbazepine | TABLET;ORAL | 078069-001 | Jan 11, 2008 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Breckenridge Pharm | OXCARBAZEPINE | oxcarbazepine | TABLET;ORAL | 078069-003 | Jan 11, 2008 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
